In this session, you’ll learn how to:
-  Understand translational biology of lipid management.
-  Understanding the treatment of lipid trials.
-  Discuss guideline recommendations.

Robert J. Chilton, DO, MACOI, Professor of Medicine, University of Texas Health Science Center

In this session, you’ll learn how to:
-  Streamline care to support the best possible patient outcomes with heart failure (HF).
-  Increase use and awareness of drugs originally developed for treating Type 2 Diabetes however, now approved for reducing cardiovascular events and mortality in patients with HF, with our without Type 2 Diabetes. 
-  Better individualize HF care while continuing to increases the number of patients receiving guideline-directed medical therapy (GDMT).

Chad Link, DO, FACOI, Associate Clinical Instructor, Michigan State University College of Osteopathic Medicine

In this session, you’ll learn how to:
-  Overview of aortic stenosis and discuss ACC/AHA guidelines for patient selection and evaluation for transcatheter aortic valve replacement.
-  Overview of mitral valve disease and discuss ACC/AHA guidelines for patient selection and evaluation for transcatheter edge-to-edge repair of the mitral valve (TEER). 
-  Overview of atrial Fibrillation and discuss indications for left atrial appendage occlusion.

Troy L. Randle, DO, FACOI, Cardiology Fellowship Program Director, RowanSOM

In this session, you’ll learn how to:
-  Define Atrial Fibrillation and review AFib mechanism.
-  Review AFib health and economic bruden.
-  Discuss rhythm management strategies with focus on AFib ablation.

Ali H. Sheikh, DO, Assistant Professor of Medicine, Michigan State University - College of Human Medicine

In this session, you’ll learn how to:
-  Consider advantages and limitations of ICU vs Non-ICU settings in common clinical scenarios.
-  Approach level of care decisions from a shared decision making perspective among providers. 
-  Ensure patients and families understand motivations for level of care decisions.

John Dahdah, DO, Staff Physician, AdventHealth Tampa

In this session, you’ll learn how to:
-  Discuss new biologics and small molecule agents that have been FDA approved in the use of IBD over the past 2 years.
-  Discuss their respective mechanisms of action. 
-  Discuss appropriate session of when to use these new agents.

Susan Kais, MD, IBD Medical Director, Advent Health Orlando

In this session, you’ll learn how to:
-  Discuss advances in medical treatment of Hepatitis C.
-  Discuss advances in endoscopy.
-  Discuss advances in IBD treatment.

Michael Raphael, DO, Assistant Clinical Professor, MSU-COM, MSU-CHM

In this session, you’ll learn how to:
-  Learn to master diagnosis and treatment of GERD, nausea and vomiting.
-  Understand Pathophysiology of peptic ulcer disease and H Pylori, bloating and gallstone disease. 
-  Learn a systematic approach to the diagnosis and management of abdominal pain and the relationship to IBS - constipation or diarrhea predominance.

Charlene A. LePane, DO, FACOI, Gastroenterologist, AdventHealth

In this session, you’ll learn how to:
-  Identify patients at risk for fracture and develop a comfort level for interpreting diagnostic tools.
-  Identify effective treatment strategies based on mechanisms of action of the FDA approved medications for osteoporosis.
-  Develop an approach for long-term care, including frequency of monitoring, consideration of drug holidays and counseling regarding conservative measures to help decrease fracture risks.

Mark Vercel, DO, Assistant Professor of Clinical Medicine, University of South Dakota Sanford School of Medicine

In this session, you’ll learn how to:
-  Develop a rational approach to the diagnosis and evaluation of vasculitis and their mimics.
-  Differentiate potential vasculitis mimics based on the size of the blood vessel involved.
-  Identify the appropriate laboratory and radiographic evaluation in assessing for vasculitis and their common mimics.

Anisha Dua, MD, Director of the Vasculitis Center, Section of Rheumatology, Northwestern University Feinberg School of Medicine

In this session, you’ll learn how to:
-  Review the CASPAR criteria for psoriatic arthritis.
-  Describe the features of a typical psoriatic presentation.
-  Briefly discuss some of the most commonly used treatment options.

Arthur M. Mandelin, MD, PhD, Associate Professor of Medicine, Northwestern University Feinberg School of Medicine

In this session, you’ll learn how to:
-  Pharmacologic approach to improve glycemic control in Type 2 diabetes.
-  Comparative data to improve glucose control with GLP receptors agonists and SGLT2 inhibitors. 
-  Discuss supporting data on cardiovascular risk reduction with both GLP receptor agonists and SGLT2 inhibitors.
-  Review data on the effectiveness of GLP receptor agonists and SGLT2 inhibitors on reducing obesity.
-  Learn new data on SGLT2 inhibitors and GLP receptor agonists pertaining to recusing renal end point.
-  Review data on the American Diabetes Association 2022 Guidelines and other organization’s statements pertaining to reducing cardiovascular and renal end points.

Jeffrey S. Freeman, DO, FACOI, Professor of Internal Medicine & Chairman of Division Endocrinology and Metabolism, Philadelphia College of Osteopathic Medicine

In this session, you’ll learn how to:
-  Discuss and understand symptoms that must be investigated in patients who have symptoms despite "well treated" hypothyroidism.
-  Discuss and understand alternative treatments of hypothyroidism symptoms.
-  Discuss and understand what can effect the thyroid blood tests and appropriate interpretation of the tests.

Jack L. Snitzer, DO, FACOI, Clinical Endocrinologist, TidalHealth Endocrinology

In this session, you’ll learn how to:
-  Understand the data backing oxygen therapy in chronic lung disease.
-  Understand the basics of home oxygen therapy. 
-  Understand the uses for portable vs stationary oxygen concentrators.

Mary R. Suchyta, DO, FACOI, Medical Director, Select Health

In this session, you’ll learn how to:
-  Define and discuss the impact of inpatient providers on Utilization Management.
-  Define and discuss the impact of inpatient providers on CDI metrics, discharges, readmissions, and length of stay. 
-  Define the partnership between Care management and inpatient providers.

Ariana L. Peters, DO, FACOI, Medical Director, Care Management, Mayo Clinic Arizona

In this session, you’ll learn how to:
-  Understand current COVID-19 primary series and booster schedules.
-  Discuss strategies to overcome hurdles faced with VCOVID-19 Vaccines.
-  Gain a deeper understanding of current COVID-19 vaccine options to dispel COVID vaccine myths.

John A. Frith, DO, Allergy/Immunology Physician, Beaumont Hospital

In this session, you’ll learn how to:
-  Identify the mechanism of action of COVID-19 vaccines.
-  Describe indications for COVID-19 vaccines. 
-  Review the adverse effects of tozinameran (BNT162b2) and mRNA-1273 SARS-Co-2.

MarkAlain Dery, DO, MPH, FACOI, Chief Innovation Officer, Access Health Louisiana

In this session, you’ll learn how to:
-  Discuss the current CDC COVID-19 Vaccine recommendations.
-  Review the most up-to-date available real-world effectiveness & safety data on real-world use of SARS CoV-2 vaccines. 
-  Discuss current/future SARS CoV-2 vaccine formulation and potential future vaccine approaches.

Liam R. Sullivan, DO, Associate Program Director Infectious Disease Fellowship, Spectrum Health-Michigan State University College of Human Medicine

In this session, you’ll learn how:
-  To review and discuss updates on the treatment for first and recurrent episodes of clostridium difficile.
-  To discuss and review diagnosis and treatment guidelines for Lyme disease.
-  To review updates on the diagnosis and treatment of sexually transmitted infections including new HIV and PrEP therapeutics.

Mia A. Taormina, DO, FACOI, Chair, Department of Infectious Disease, Duly Health and Care

In this session, you’ll learn how to:
-  Discuss the epidemiology, clinical manifestations and treatment of monkeypox.
-  Define the risks and benefits of vaccination and/or treatment.
-  Discuss the current outbreak and to avoid spread of stigma surrounding this infection.

Patrick J. Kenney, DO, FACOI, Vice Chair, Department of Infectious Disease, Cleveland Clinic Florida

In this session, you’ll learn how to:
-  Increase awareness of tickborne illnesses and to understand the impact of climate change on the ever expanding habitats where these vectors can be found.

Gerald W. Blackburn, DO, MACOI, Clinical Professor of Medicine, Michigan State University, College of Osteopathic Medicine

Bryan L. Martin, DO, MACOI, Emeritus Professor of Medicine, The Ohio State University

In this session, you’ll learn:
-  The populations affected by variants of APOL1.
-  Inheritance of APOL1 variants.
-  Effect of APOL1 on kidney disease.

John E. Prior, DO, FACOI, Clinical Associate Professor of Medicine, The Geisinger Commonwealth School of Medicine

In this session, you’ll learn how to:
-  TBD
-  TBD 
-  TBD

Steven Sozio, MD, Associate Professor Medicine, Division of Nephrology, Johns Hopkins School of Medicine

In this session, you’ll learn how to:
-  Discuss the staging and stratification of patients with myelodysplastic syndrome.
-  Discuss current standards of care for treating myelodysplastic syndrome for both low and high risk patients.

Gregory Harris, DO, FACOI, Hematology and Oncology, Harbin Clinic

In this session, you’ll learn how to:
-  Understand the issues surrounding medically fragile patients receiving home care.
-  Learn to help patients and families make decision about treatment bases on goals of care. 
-  Understand the transition to hospice and what level of care is appropriate and when.

Marianne M. Holler, DO, FACOI, Chief Medical Officer, VNA Health Group